Broadening the spectrum of small-molecule antibacterials by metallic nanoparticles to overcome microbial resistance

International Journal of Pharmaceutics

Volumn 532, Issue 1, 2017, Pages 139-148

  Rai, Mahendra ^a   Ingle, Avinash P ^a   Pandit, Raksha ^a   Paralikar, Priti ^a   Gupta, Indarchand ^a   Chaud, Marco V ^b   dos Santos, Carolina Alves ^b  

^a SANT GADGE BABA AMRAVATI UNIVERSITY   (India)

^b UNIVERSITY OF SOROCABA   (Brazil)

Author keywords

Antimicrobials; Drug resistance; Nanomedicine; Nanoparticles; Nanotechnology

Indexed keywords

ALUMINIUM OXIDE NANOPARTICLE; ANTIBIOTIC AGENT; BISMUTH NANOPARTICLE; COPPER NANOPARTICLE; COPPER OXIDE NANOPARTICLE; GOLD NANOPARTICLE; MAGNESIUM OXIDE NANOPARTICLE; METAL NANOPARTICLE; POLYMER; SELENIUM NANOPARTICLE; SILVER NANOPARTICLE; TITANIUM DIOXIDE NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; ZINC OXIDE NANOPARTICLE; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; DRUG CONJUGATION; DRUG MECHANISM; ENTEROCOCCUS FAECIUM; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; POLYMERIZATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANIMAL; DRUG DELIVERY SYSTEM; DRUG EFFECT;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, BACTERIAL; METAL NANOPARTICLES; POLYMERS;

EID: 85028978600     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2017.08.127     Document Type: Review

References (128)

1. Abdel-Rahim, K.A.A., Mohamed, A.M.A., Bactericidal and antibiotic synergistic effect of nanosilver against methicillin-resistant Staphylococcus aureus. Jundishapur J. Microbiol., 8(11), 2015, e25867, 10.5812/jjm.25867.
2. Abed, N., Hassane, F.S., Zouhiri, F., Mougin, J., Nicolas, V., Desmaële, D., Gref, R., Couvreur, P., An efficient system for intracellular delivery of beta-lactam antibiotics to overcome bacterial resistance. Sci. Rep., 5, 2015, 13500, 10.1038/srep13500.
3. Agarwala, M., Choudhury, B., Yadav, R.N.S., Comparative study of antibiofilm activity of copper oxide and iron oxide nanoparticles against multidrug resistant biofilm forming uropathogens. Indian J. Microbiol. 54 (2014), 365–368.
4. Al-Hartomy, O.A., Mujahid, M., Synthesis and characterization of zinc oxide nanosheets for protection against multiple drug resistance bacteria (MDR). Am. J. Biol. Chem. 2 (2014), 17–22.
5. Allahverdiyev, A.M., Kon, K.V., Abamor, E.S., Bagirova, M., Rafailovich, M., Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents. Expert Rev. Anti. Infect. Ther. 9 (2011), 1035–1052.
6. 3 nanoparticles against multidrug resistance strains of Staphylococcus aureus isolated from skin exudates. J. Nanopart. Res., 15, 2013, 1970, 10.1007/s11051-013-1970-1.
7. 3 nanoparticles with Escherichia coli and their cell envelope biomolecules. J. Appl. Microbiol. 116 (2014), 772–783.
8. 3 nanoparticles and their bactericidal potential against clinical isolates of multi-drug resistant Pseudomonas aeruginosa. World J. Microbiol. Biotechnol. 31 (2015), 153–164.
9. 2 nanoparticles against MDR Pseudomonas aeruginosa. J. Expt. Nanosci. 10 (2015), 819–827.
10. Ashajyothi, C., Jahanara, K., Chandrakanth, K.R., Biosynthesis and characterization of copper nanoparticles from Enterococcus faecalis. Int. J. Pharm. Bio. Sci. 5 (2014), 204–211.
11. Ashajyothi, C., Manjunath Narasanna, R., Kelmani, C.R., Antibacterial activity of biogenic zinc oxide nanoparticles synthesized from Enterococcus faecalis. Int. J. Chem. Tech. Res. 6 (2014), 3131–3136.
12. Balland, O., Pinto-Alphandary, H., Viron, A., Puvion, E., Andremont, A., Couvreur, P., Intracellular distribution of ampicillin in murine macrophages infected with Salmonella typhimurium and treated with (3H) ampicillin-loaded nanoparticles. J. Antimicrob. Chemother. 37 (1996), 105–115.
13. Bawskar, M., Deshmukh, S., Bansod, S., Gade, A., Rai, M., Comparative analysis of biosynthesised and chemosynthesised silver nanoparticles with special reference to their antibacterial activity against pathogens. IET Nanobiotechnol. 9 (2015), 107–113.
14. Behera, S., Nayak, P.L., In vitro antibacterial activity of green synthesized silver nanoparticles using jamun extract against multiple drug resistant bacteria. World J. Nano Sci. Technol. 2 (2013), 62–65.
15. Beyth, N., Houri-Haddad, Y., Domb, A., Khan, W., Hazan, R., Alternative antimicrobial approach: nano-antimicrobial materials. Evid. Based Complement. Alter Nat. Med., 2015, 10.1155/2015/246012.
16. Birla, S.S., Tiwari, V.V., Gade, A.K., Ingle, A.P., Yadav, A.P., Rai, M.K., Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Lett. Appl. Microbiol. 48 (2009), 173–179.
17. Bondarenko, O., Juganson, K., Ivask, A., Kasemets, K., Mortimer, M., Kahru, A., Toxicity of Ag, CuO and ZnO nanoparticles to selected environmentally relevant test organisms and mammalian cells in vitro: a critical review. Arch. Toxicol. 87:7 (2013), 1181–1200.
18. Brown, A.N., Smith, K., Samuels, T.A., Lu, J., Obare, S.O., Scott, M.E., Nanoparticles func-tionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus. Appl. Environ. Microbiol. 78 (2012), 2768–2774.
19. Burygin, G.L., Khlebtsov, B.N., Shantrokha, A.N., Dykman, L.A., Bogatyrev, V.A., Khlebtsov, N.G., On the enhanced antibacterial activity of antibiotics mixed with goldnanoparticles. Nanoscale Res. Lett. 4:8 (2009), 794–801.
20. 2 photocatalysis damages lipids and proteins in Escherichia coli. Appl. Environ. Microbiol. 80 (2014), 2573–2581.
21. Carrillo-Carrion, C., Nazarenus, M., Paradinas, S.S., Carregal-Romero, S., Almendral, M.J., Fuentes, M., Pelaz, B., del Pino, P., Hussain, I., Clift, M.J.D., Rothen-Rutishauser, B., Liang, X.J., Parak, W.J., Metal ions in the context of nanoparticles toward biological applications. Curr. Opin. Chem. Eng. 4 (2014), 88–96.
22. Cavassin, E.D., Poli de, Figueiredo, Otoch, L.F., Seckler, J.P., de Oliveira, M.M., Franco, R.A., Marangoni, F.F., Zucolotto, V.S., Shafferman, V., Levin, A.S., Costa, S.F., Comparison of methods to detect the in vitro activity of silver nanoparticles (AgNPs) against multidrug resistant bacteria. J. Nanobiotechnol., 13, 2015, 64, 10.1186/s12951-015-0120-6.
23. Chatterjee, A.K., Chakraborty, R., Basu, T., Mechanism of antibacterial activity of copper nanoparticles. Nanotechnology, 25, 2014, 135101, 10.1088/0957-4484/25/13/135101.
24. Chaurasia, A.K., Thorat, N.D., Tandon, A., Kim, J.H., Park, S.H., Kim, K.K., Coupling of radiofrequency with magnetic nanoparticles treatment as an alternative physical antibacterial strategy against multiple drug resistant bacteria. Sci. Rep., 6, 2016, 33662, 10.1038/srep33662.
25. Choi, K.H., Lee, H.J., Park, B.J., Wang, K.K., Shin, E.P., Park, J.C., Kim, Y.K., Oh, M.K., Kim, Y.R., Photosensitizer and vancomycin-conjugated novel multifunctional magnetic particles as photoinactivation agents for selective killing of pathogenic bacteria. Chem. Commun. 48 (2012), 4591–4593.
26. Choi, S.K., Myc, A., Silpe, J.E., Sumit, M., Wong, P.T., McCarthy, K., Desai, A.M., Thomas, T.P., Kotlyar, A., Holl, M.M., Orr, B.G., Baker, J.R., Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface. ACS Nano 7 (2013), 214–228.
27. Cioffi, N., Rai, M., Nano-antimicrobials: Synthesis and Characterization of Novel Nano Antimicrobials. 2012, Springer, Berlin Heidelberg.
28. Cremonini, E., Zonaro, E., Donini, M., Lampis, S., Boaretti, M., Dusi, S., Melotti, P., Lleo, M.M., Vallini, G., Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts. Microbial. Biotechnol. 9 (2016), 758–771.
29. Durairaj, C., Kadam, R.S., Chandler, J.W., Hutcherson, S.L., Kompella, U.B., Nanosized dendritic polyguanidilyated translocators for enhanced solubility, permeability, and delivery of gatifloxacin. Invest. Ophthalmol. Vis. Sci. 51 (2010), 5804–5816.
30. Ehsan, S., Sajjad, M., Bioinspired synthesis of zinc oxide nanoparticle and its combined efficacy with different antibiotics against multidrug resistant bacteria. J. Biomater. Nanobiotechnol. 8 (2017), 159–175.
31. Fayaz, A.M., Balaji, K., Girilal, M., Yadav, R., Kalaichelvan, P.T., Venketesan, R., Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria. Nanomedicine 6:1 (2010), 103–109.
32. Fayaz, A.M., Girilal, M., Mahdy, S.A., Somsundar, S.S., Venkatesan, R., Kalaichelvan, P.T., Vancomycin bound biogenic gold nanoparticles: a different perspective for development of anti VRSA agents. Process Biochem. 46:3 (2011), 636–641.
33. Fernandez, J., Bert, F., Nicolas-Chanoine, M.H., The challenges of multi-drug-resistance in hepatology. J. Hepatol. 65 (2016), 1043–1054.
34. Figueroa-Quintanilla, D., Salazar-Lindo, E., Sack, R.B., León-Barúa, R., Sarabia-Arce, S., Campos-Sánchez, M., Eyzaguirre-Maccan, E., A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease. N. Engl J. Med. 328 (1993), 1653–1658.
35. Golinska, P., Rathod, D., Wypij, M., Gupta, I., Składanowski, M., Paralikar, P., Dahm, H., Rai, M., Mycoendophytes as efficient synthesizers of bionanoparticles: nanoantimicrobials, mechanism, and cytotoxicity. Crit. Rev. Biotechnol. 17 (2016), 1–14.
36. Gopinath, P.M., Narchonai, G., Dhanasekaran, D., Ranjani, A., Thajuddin, N., Mycosynthesis, characterization and antibacterial properties of AgNPs against multidrug resistant (MDR) bacterial pathogens of female infertility cases. Asian J. Pharma Sci. 10 (2015), 138–145.
37. Gu, H.W., Ho, P.L., Tong, E., Wang, L., Xu, B., Presenting vancomycin on nanoparticles to enhance antimicrobial activities. Nano Lett. 3 (2003), 1261–1263.
38. Gupta, I., Duran, N., Rai, M., Nano-silver toxicity: emerging concerns and consequences in human health. Rai, M., Cioffi, N., (eds.) Nano-antimicrobials: Progress and Prospects, 2012, Springer, Verlag Germany, 525–548 Rai M, Cioffi N (ed).
39. 2 nanoparticles on pathogenic strain of E coli. Int. J. Adv. Biotechnol. Res. 3 (2012), 621–624.
40. Hamed, S., Emara, M., Shawky, R.M., El-domany, R.A., Youssef, T., N-acetyl cysteine substantially enhances the antimicrobial activity of zinc oxide nanoparticles against multidrug resistant pathogens. Int. J. Adv. Res. Biol. Sci. 2 (2015), 45–59.
41. Hameed, A.S., Karthikeyan, C., Ahamed, A.P., Thajuddin, N., Alharbi, N.S., Alharbi, S.A., Ravi, G., In vitro antibacterial activity of ZnO and Nd doped ZnO nanoparticles against ESBL producing Escherichia coli and Klebsiella pneumoniae. Sci. Rep., 6, 2016, 24312, 10.1038/srep24312.
42. He, J., Abdelraouf, K., Ledesma, K.R., Chow, D.S., Tam, V.H., Pharmacokinetics and efficacy of liposomal polymyxin B in a murine pneumonia model. Int. J. Antimicrob. Agents 42 (2013), 559–564.
43. Hernandez-Delgadillom, R., Velasco-Arias, D., Diaz, D., Arevalo-Niño, K., Garza-Enriquez, M., De la Garza-Ramos, M.A., Cabral-Romero, C., Zerovalent bismuth nanoparticles inhibit Streptococcus mutans growth and formation of biofilm. Int. J. Nanomed. 7 (2012), 2109–2113.
44. Holmstrup, P., Klausen, B., The growing problem of antimicrobial resistance. Oral Dis., 2017, 10.1111/odi.12610.
45. Hoseinzadeh, E., Makhdoumi, P., Taha, P., Stelling, J., Hossini, H., Kamal, M.A., Ashraf, G.M., A review on nano-antimicrobials: metal nanoparticles, methods, and mechanisms. Curr. Drug Metab, 2016, 10.2174/1389200217666161201111146 (Accessed on 10th June, 2017) http://www.nanowerk.com/spotlight/spotid=32188.php.
46. Huang, Z., Zheng, X., Yan, D., Yin, G., Liao, X., Kang, Y., Yao, Y., Huang, D., Hao, B., Toxicological effect of ZnO nanoparticles based on bacteria. Langmuir 24 (2008), 4140–4144.
47. Huh, A.J., Kwon, Y.J., Nanoantibiotics: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J. Controlled Rel. 156 (2011), 128–145.
48. Ibrahim, H.M., El-Bisi, M.K., Taha, G.M., El-Alfy, E.A., Chitosan nanoparticles loaded antibiotics as drug delivery biomaterial. J. Appl. Pharm. Sci. 5:10 (2015), 085–090.
49. Ingle, A., Gade, A., Pierrat, S., Sonnichsen, C., Rai, M., Mycosynthesis of silver nanoparticles using the fungus Fusarium acuminatum and its activity against some human pathogenic bacteria. Curr. Nanosci. 4 (2008), 141–144.
50. Ingle, A.P., Duran, N., Rai, M., Bioactivity, mechanism of action, and cytotoxicity of copper-based nanoparticles. A Rev. Appl. Microbiol. Biotechnol. 98 (2009), 1001–1009.
51. Ivask, A., Juganson, K., Bondarenko, O., Mortimer, M., Aruoja, V., Kasemets, K., Blinova, I., Heinlaan, M., Slaveykova, V., Kahru, A., Mechanisms of toxic action of Ag, ZnO and CuO nanoparticles to selected ecotoxicological test organisms and mammalian cells in vitro: a comparative review. Nanotoxicology 1 (2014), 57–71.
52. Jan, T., Iqbal, J., Ismail, M., Zakaullah, M., Naqvi, S.H., Badshah, N., Sn doping induced enhancement in the activity of ZnO nanostructures against antibiotic resistant Saureus bacteria. Int. J. Nanomed. 8 (2013), 3679–3687.
53. Jiang, H., Xiong, M., Bi, Q., Wang, Y., Li, C., Self-enhanced targeted delivery of a cell wall- and membrane-active antibiotics, daptomycin, against Staphylococcal pneumonia. Acta Pharm. Sin. B 6 (2016), 319–328.
54. Kalam, M.A., Sultana, Y., Ali, A., Aqil, M., Mishra, A.K., Chuttani, K., Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system. J. Drug Target 18 (2010), 191–204.
55. Kalam, M.A., Sultana, Y., Ali, A., Aqil, M., Mishra, A.K., Chuttani, K., Aljuffali, I.A., Alshamsan, A., Part II: enhancement of transcorneal delivery of gatifloxacin by solid lipid nanoparticles in comparison to commercial aqueous eye drops. J. Biomed. Mater. Res. A 101 (2013), 1828–1836.
56. Kar, D., Bandyopadhyay, S., Dimri, U., Mondal, D.B., Nanda, P.K., Das, A.K., Batabyal, S., Dandapat, P., Bandyopadhyay, S., Antibacterial effect of silver nanoparticles and capsaicin against MDR-ESBL producing Escherichia coli: An in vitro study. Asian Pac. J. Trop. Dis. 6 (2016), 807–810.
57. Kim, S., Choi, J.E., Choi, J., Chung, K., Park, K., Yi, J., Ryu, D., Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol. In Vitro 23 (2009), 1076–1084.
58. Koper, O., Klabunde, J., Marchin, G., Klabunde, K.J., Stoimenov, P., Bohra, L., Nanoscale powders and formulations with biocidal activity toward spores and vegetative cells of bacillus species viruses, and toxins. Curr. Microbiol. 44 (2002), 49–55.
59. Lara, H.H., Ayala-Núñez, N.V., IxtepanTurrent, L.C., Rodrı́guez Padilla, C., Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria. World J. Microbiol. Biotechnol. 26 (2010), 615–621.
60. Larsen, S.T., Jackson, P., Poulsen, S.S., Levin, M., Jensen, K.A., Wallin, H., Nielsen, G.D., Koponen, I.K., Airway irritation, inflammation, and toxicity in mice following inhalation of metal oxide nanoparticles. Nanotoxicology 10 (2016), 1254–1262.
61. Lellouche, J., Friedman, A., Gedanken, A., Banin, E., Antibacterial and antibiofilm properties of yttrium fluoride nanoparticles. Int. J. Nanomed. 7 (2012), 5611–5624.
62. Li, P., Li, J., Wu, C., Wu, Q., Li, J., Synergistic antibacterial effects of b-lactam antibiotic combined with silver nanoparticles. Nanotechnology 16 (2005), 1912–1917.
63. Li, S., Wu, C., Zhao, X., Jiang, H., Yan, H., Wang, X., Synergistic antibacterial activity of new isomeric carborane derivatives through combination with nanoscaled titania. J. Biomed. Nanotechnol. 9 (2013), 393–402.
64. Li, X., Robinson, S.M., Gupta, A., Saha, K., Jiang, Z., Moyano, D.F., Ali, S., Riley, M.A., Rotellob, V.M., Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria. ACS Nano 8 (2014), 10682–10686.
65. Li, H., Chen, Q., Zhao, J., Urmila, K., Enhancing the antimicrobial activity of natural extraction using the synthetic ultra-small metal nanoparticles. Sci. Rep., 5, 2015, 11033, 10.1038/srep11033.
66. Lima, E., Guerra, R., Lara, V., Guzmán, A., Gold nanoparticles as efficient antimicrobial agents for Escherichia coli and Salmonella typhi. Chem. Cent. J. 7 (2013), 1–7.
67. Liu, G.Y., Omri, A., Liposomal Vancomycin for the Treatment of MRSA Infections. 2014 (US 2014/0205654 A1.).
68. Lotfipour, F., Abdollahi, S., Jelvehgari, M., Valizadeh, H., Hassan, M., Milani, M., Study of antimicrobial effects of vancomycin loaded PLGA nanoparticles against Enterococcus clinical isolates. Drug Res. (Stuttg) 64:7 (2013), 348–352.
69. Luo, Y., Hossain, M., Wang, C., Qiao, Y., An, J., Ma, L., Su, M., Targeted nanoparticles for enhanced X-ray radiation killing of multidrug-resistant bacteria. Nanoscale 5 (2013), 687–694.
70. Maev, I.V., Samsonov, A.A., Golubev, N.N., Bismuth preparations in the treatment of patients with gastric and duodenal ulcer disease. Klin. Med. (Mosk) 86:9 (2008), 57–63.
71. Makhluf, S., Dror, R., Nitzan, Y., Abramovich, Y., Jelinek, R., Gedanken, A., Microwave-assisted synthesis of nanocrystalline MgO and its use as a bacteriocide. Adv. Funct. Mater. 15 (2005), 1708–1715.
72. Malka, E., Perelshtein, I., Lipovsky, A., Shalom, Y., Naparstek, L., Perkas, N., Patick, T., Lubart, R., Nitzan, Y., Banin, E., Gedanken, A., Eradication of multi-drug resistant bacteria by a novel Zn-doped CuO nanocomposite. Small 9 (2013), 4069–4076.
73. Mandal, D., Bolander, M.E., Mukhopadhyay, D., Sarkar, G., Mukherjee, P., The use of microorganisms for the formation of metal nanoparticles and their application. Appl. Microbiol. Biotechnol. 69:5 (2006), 485–492.
74. Marinho, C.M., Santos, T., Alexandre, G., Poeta, P., Igrejas, G., A decade long commitment to antimicrobial resistance surveillance in Portugual. Front. Microbiol. 7 (2016), 1–14.
75. Mirhosseini, M., Synergistic antibacterial effect of metal oxide nanoparticles and ultrasound stimulation. J. Biol. Today's World 4:6 (2015), 138–144.
76. Mugabe, C., Halwani, M., Azghani, A.O., Lafrenie, R.M., Omri, A., Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa, Antimicrob. Agents Chemother. 50:6 (2006), 2016–2022.
77. Nanda, A., Saravanan, M., Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE. Nanomedicine 5 (2009), 452–456.
78. Naqvi, S.Z., Kiran, U., Ali, M.I., Jamal, A., Hameed, A., Ahmed, S., Ali, N., Combined efficacy of biologically synthesized silver nanoparticles and different antibiotics against multidrug resistant bacteria. Int. J. Nanomed. 8 (2013), 3187–3195.
79. Navarro, E., Piccapietra, F., Wagner, B., Marconi, F., Kaegi, R., Odzak, N., Sigg, L., Behra, R., Toxicity of silver nanoparticles to Clamydomonas reinhardtii. Environ. Sci. Technol. 42 (2008), 8959–8964.
80. Nguyen, T.H.D., Vardhanabhuti, B., Lin, M., Mustapha, A., Antibacterial properties of selenium nanoparticles and their toxicity to Caco-2 cells. Food Control 77 (2017), 17–24.
81. Nikaido, H., Multidrug resistance in bacteria. Ann. Rev. Biochem. 78 (2009), 119–146.
82. O'Neill, J., Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Rev Antimicrob Resist., 2014 (Accessed on 05th June, 2017) https://amr-review.org/.
83. Omri, A., Suntres, Z.E., Shek, P.N., Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem. Pharmacol. 64 (2002), 1407–1413.
84. Palanisamy, N.K., Ferina, N., Amirulhusni, A.N., Mohd-Zain, Z., Hussaini, J., Ping, L.J., Durairaj, R., Antibiofilm properties of chemically synthesized silver nanoparticles found against Pseudomonas aeruginosa. J. Biotechnol., 12, 2014, 2, 10.1186/1477-3155-12-2.
85. Patra, J.K., Baek, K.H., Antibacterial activity and synergistic antibacterial potential of biosynthesized silver nanoparticles against foodborne pathogenic bacteria along with its anticandidal and antioxidant effects. Front. Microbiol., 2017, 10.3389/fmicb.2017.00167.
86. Patra, P., Mitra, S., Debnath, N., Pramanik, P., Goswami, A., Ciprofloxacin conjugated zinc oxide nanoparticle: a camouflage towards multidrug resistant bacteria. Bull. Mater. Sci. 37 (2014), 199–206.
87. Percival, S.L., Bowler, P.G., Dolman, J., Antimicrobial activity of silver-containing dressings on wound microorganisms using an in vitro biofilm model. Int. Wound J. 4 (2007), 186–191.
88. Pumerantz, A., Muppidi, K., Agnihotri, S., Guerra, C., Venketaraman, V., Wang, J., Betageri, G., Preparation of liposomal vancomycin and intracellular killing of meticillin-resistant Staphylococcus aureus (MRSA). Int. J. Antimicrob. Agents 37 (2011), 140–144.
89. Qi, G., Li, L., Yu, F., Wang, H., Vancomycin-modified mesoporous silica nanoparticles for selective recognition and killing of pathogenic gram-positive bacteria over macrophage-like cells. ACS Appl. Mater. Interfaces 5 (2013), 10874–10881.
90. Radovic-Moreno, A.F., Lu, T.K., Puscasu, V.A., Yoon, C.J., Langer, R., Farokhzad, O.C., Surface charge-switching polymeric nanoparticles for bacterial cell wall targeted delivery of antibiotics. ACS Nano 6 (2012), 4279–4287.
91. Rai, M.K., Deshmukh, S.D., Ingle, A.P., Gade, A.K., Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria. J. Appl. Microbiol. 112 (2012), 841–852.
92. Rai, M., Paralikar, P., Jogee, P., Agarkar, G., Ingle, A.P., Derita, M., Zacchino, S., Synergistic antimicrobial potential of essential oils in combination with nanoparticles: emerging trends and future perspectives. Int. J. Pharm. 519 (2017), 67–78.
93. Ramyaa, S., Shanmugasundarama, T., Balagurunathan, R., Biomedical potential of actinobacterially synthesized selenium nanoparticles with special reference to anti-biofilm, antioxidant, wound healing, cytotoxic and anti-viral activities. J. Trace Elements Med. Biol. 32 (2015), 30–39.
94. Ranghar, S., Sirohi, P., Verma, P., Agarwal, V., Nanoparticle-based drug delivery systems: promising approaches against infections. Braz. Arch. Biol. Technol 57 (2014), 209–222.
95. Roy, A.S., Parveen, A., Koppalkar, A.R., Prasad, M., Effect of nano-titanium dioxide with different antibiotics against methicillin-resistant Staphylococcus aureus. J. Biomater. Nanobiotechnol. 1 (2010), 37–41.
96. Roy, A.S., Parveen, A., Koppalkar, A.R., Prasad, M.V.N.A., Effect of nano-titanium dioxide with different antibiotics against methicillin-resistant Staphylococcus aureus. J. Biomater. Nanobiotechnol. 1 (2010), 37–41.
97. Rudramurthy, G.R., Swamy, M.K., Sinniah, U.R., Ghasemzadeh, A., Nanoparticles: aternatives against drug-resistant pathogenic microbes. Molecules, 21, 2016, 836, 10.3390/molecules21070836.
98. Sande, L., Sanchez, M., Montes, J., Wolf, A.J., Morgan, M.A., Omri, A., Liu, G.Y., Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model. J. Antimicrob. Chemother. 67 (2012), 2191–2194.
99. Sandoval-Motta, S., Maximino, A., Adaptive resistance to antibiotics in bacteria: a systems biology perspective. WIRES Syst. Biol. Med. 8 (2016), 253–267.
100. Santoro, C.M., Duchsherer, N.L., Grainger, D.W., Antimicrobial efficacy and ocular cell toxicity from silver nanoparticles. Nanobiotechnology 3:2 (2007), 55–65.
101. Santos, C.A., Seckler, M.M., Ingle, A., Gupta, I., Galdiero, S., Galdiero, M., Gade, A., Rai, M.K., Silver nanoparticles: therapeutical uses, toxicity, and safety issues. J. Pharm. Sci. 103 (2014), 1931–1944.
102. Shaker, M.A., Shaaban, M.I., Synthesis of silver nanoparticles with antimicrobial and anti-adherence activities against multidrug-resistant isolates from Acinetobacter baumannii. J. Taibah Uni. Med. Sci. 12:4 (2017), 291–297.
103. Shareena-Dasari, T.P., Zhang, Y., Yu, H., Antibacterial activity and cytotoxicity of gold (i) and (iii) ions and gold nanoparticles. Biochem. Pharmacol., 4, 2015, 199, 10.4172/2167-0501.1000199.
104. Shimanovich, U., Gedanken, A., Nanotechnology solutions to restore antibiotic activity. J. Mater. Chem. B 4 (2016), 824–833.
105. Singh, D., Rathod, V., Ninganagouda, S., Hiremath, J., Singh, A.K., Mathew, J., Optimization and characterization of silver nanoparticle by endophytic fungi Penicillium sp: isolated from Curcuma longa (Turmeric) and application studies against MDR E. coli and S. aureus. Bioinorg. Chem. Appl., 2014, 2014, 10.1155/2014/408021.
106. Srivastava, N., Mukhopadhyay, M., Green synthesis and structural characterization of selenium nanoparticles and assessment of their antimicrobial property. Bioproc. Biosyst. Eng. 38:9 (2015), 1723–1730.
107. Stoimenov, P.K., Klinger, R.L., Marchin, G.L., Klabunde, K.J., Metal oxide nanoparticles as bactericidal agents. Langmuir 18 (2002), 6679–6686.
108. Sukwong, P., Somkid, K., Kongseng, S., Pissuwan, D., Yoovathaworn, K., Respiratory tract toxicity of titanium dioxide nanoparticles and multi-walled carbon nanotubes on mice after intranasal exposure. Micro Nano Lett. 11 (2016), 183–187.
109. Tang, Z.X., Lv, B.F., MgO nanoparticles as antibacterial agent: preparation and activity. Braz. J. Chem. Eng. 31 (2014), 591–601.
110. Tanwar, J., Das, S., Fatima, Z., Hameed, S., Multidrug resistance an emerging crisis. Interdiscip. Perspect. Infect. Dis. 1 (2014), 1–7.
111. Taylor, E., Webster, T.J., Reducing infections through nanotechnology and nanoparticles. Int. J. Nanomed. 6 (2011), 1463–1473.
112. Thapa, P., Bhagat, C., Shrestha, P., Awal, S., Dudhagara, P., Enzyme-mediated formulation of stable elliptical silver nanoparticles tested against clinical pathogens and MDR bacteria and development of antimicrobial surgical thread. Ann. Clin. Microbiol. Antimicrob., 16, 2017, 39, 10.1186/s12941-017-0216-y.
113. Tillman, L.A., Drake, F.M., Dixon, J.S., Wood, J.R., Safety of bismuth in the treatment of gastrointestinal diseases. Aliment Pharmacol. Ther. 10 (1996), 459–467.
114. Tiwari, P.M., Vig, K., Dennis, V.A., Singh, S.R., Functionalized gold nanoparticles and their biomedical applications. Nanomaterials 1 (2011), 31–63.
115. Tran, P.A., Webster, T.J., Selenium nanoparticles inhibit Staphylococcus aureus growth. Int. J. Nanomed. 6 (2011), 1553–1558.
116. Valerio-García, R.C., Carbajal-Hernández, A.L., Martínez-Ruíz, E.B., Jarquín-Díaz, V.H., Haro-Pérez, C., Martínez-Jerónimo, F., Exposure to silver nanoparticles produces oxidative stress and affects macromolecular and metabolic biomarkers in the goodeid fish Chapalichthys pardalis. Sci. Total Environ. 583 (2017), 308–318.
117. 2 and MgO nanoparticles. J. Biomat. Nanobiotechnol. 4 (2013), 365–373.
118. Vinoj, G., Pati, R., Sonawane, A., Vaseeharana, B., In Vitro cytotoxic effects of gold nanoparticles coated with functional acyl homoserine lactone lactonase protein from Bacillus licheniformis and their antibiofilm activity against Proteus Species. Antimicrob. Agents Chemother. 59:2 (2015), 763–771.
119. Vyas, S.P., Kannan, M.E., Jain, S., Mishra, V., Singh, P., Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int. J. Pharm. 269 (2004), 37–49.
120. Wacker, M.G., Proykova, A., Mendes, G., Santos, L., Dealing with nanosafety around the globe regulation vs innovation. Int. J. Pharma 509 (2016), 95–106.
121. Wang, Y., Zhu, L., Dong, Z., Xie, S., Chen, X., Lu, M., Wang, X., Li, X., Zhou, W., Preparation and stability study of norfloxacin-loaded solid lipid nanoparticle suspensions. Colloids Surf. B Biointerfaces 98 (2012), 105–111.
122. Wang, P., Lombi, E., Sun, S., Checkel, K.G., Malysheva, A., McKenn, B.A., Menzies, N.W., Zhao, F.J., Kopittke, P.M., Characterizing the uptake, accumulation and toxicity of silver sulfide nanoparticles in plants. Environ. Sci. Nano 4 (2017), 448–460.
123. Xie, Y., He, Y., Irwin, P.L., Jin, T., Shi, X., Antibacterial activity and mechanism of action of zinc oxide nanoparticles against Campylobacter jejuni. Appl. Environ. Microbiol. 77 (2011), 2325–2331.
124. Xing, B.G., Ho, P.L., Yu, C.W., Chow, K.H., Gu, H.W., Xu, B., Self-assembled multivalent vancomycin on cell surfaces against vancomycin-resistant enterococci (VRE). Chem. Commun. 17 (2003), 2224–2225.
125. 2 levels increase the toxicity of ZnO nanoparticles to goldfish (Carassius auratus) in a water-sediment ecosystem. J. Hazard. Mater. 327 (2017), 64–70.
126. Zaru, M., Sinico, C., De Logu, A., Caddeo, C., Lai, F., Manca, M.L., Fadda, A.M., Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation. J. Liposome Res. 19 (2009), 68–76.
127. Zhang, L., Pornpattananangkul, D., Hu, C.M.J., Huang, C.M., Development of nanoparticles for antimicrobial drug delivery. Curr. Med. Chem. 17 (2010), 585–594.
128. Zhao, Y., Chen, Z., Chen, Y., Xu, J., Li, J., Jiang, X., Synergy of non-antibiotic drugs and pyrimidinethiol on gold nanoparticles against superbugs. J. Am. Chem. Soc. 135 (2013), 12940–12943.